FCM
Farallon Capital Management Portfolio holdings
AUM
$21.3B
This Quarter Return
+7.59%
1 Year Return
+23.12%
3 Year Return
+87.19%
5 Year Return
+183.94%
10 Year Return
+836.54%
AUM
$8.79B
AUM Growth
+$8.79B
(+8.4%)
Cap. Flow
+$363M
Cap. Flow
% of AUM
4.13%
Top 10 Holdings %
Top 10 Hldgs %
51.77%
Holding
99
New
29
Increased
20
Reduced
18
Closed
19
Top Buys
| 1 |
AABA
Altaba Inc. Common Stock
AABA
|
$677M |
| 2 |
BCR
CR Bard Inc.
BCR
|
$463M |
| 3 |
MBLY
Mobileye N.V.
MBLY
|
$257M |
| 4 |
NXP Semiconductors
NXPI
|
$166M |
| 5 |
Huntsman Corp
HUN
|
$140M |
Top Sells
| 1 |
YHOO
Yahoo Inc
YHOO
|
$463M |
| 2 |
BEAV
B/E Aerospace Inc
BEAV
|
$322M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
$319M |
| 4 |
WWAV
The WhiteWave Foods Company
WWAV
|
$205M |
| 5 |
Eli Lilly
LLY
|
$134M |
Sector Composition
| 1 | Technology | 27.51% |
| 2 | Communication Services | 23.99% |
| 3 | Healthcare | 13.79% |
| 4 | Industrials | 6.24% |
| 5 | Consumer Discretionary | 4.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
INFO
26
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $123M | 1.28% | 2,790,700 -1,022,902 | -27% | -$45M |
|
27
Charter Communications
CHTR
$36.3B
| $113M | 1.17% | 334,825 -208,205 | -38% | -$70.1M |
|
|
TMH
28
DELISTED
Team Health Holdings Inc
TMH
| $105M | 1.09% | 2,298,900 | – | – |
|
29
VEON
VEON
$4.05B
| $79.9M | 0.83% | 20,433,518 +9,999,096 | +96% | +$39.1M |
|
30
AbbVie
ABBV
$372B
| $60.5M | 0.63% | +835,000 | New | +$60.5M |
|
31
Biogen
BIIB
$19.4B
| $57.7M | 0.6% | +212,500 | New | +$57.7M |
|
|
CLVS
32
DELISTED
Clovis Oncology, Inc.
CLVS
| $57.1M | 0.59% | 610,000 +530,000 | +663% | +$49.6M |
|
|
AGN
33
DELISTED
Allergan plc
AGN
| $55.3M | 0.57% | 227,500 -420,000 | -65% | -$102M |
|
|
NORD
34
DELISTED
Nord Anglia Education, Inc.
NORD
| $50M | 0.52% | +1,535,000 | New | +$50M |
|
|
PTLA
35
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $48M | 0.5% | 855,000 +470,000 | +122% | +$26.4M |
|
36
Humana
HUM
$36.5B
| $43M | 0.45% | 178,500 -20,000 | -10% | -$4.81M |
|
37
Verisk Analytics
VRSK
$37.5B
| $40.7M | 0.42% | +482,827 | New | +$40.7M |
|
|
WBMD
38
DELISTED
WebMD Health Corp.
WBMD
| $39.8M | 0.41% | +679,130 | New | +$39.8M |
|
39
Elevance Health
ELV
$71.8B
| $39.5M | 0.41% | +210,000 | New | +$39.5M |
|
|
IMMU
40
DELISTED
Immunomedics Inc
IMMU
| $37.3M | 0.39% | 4,227,500 +72,500 | +2% | +$640K |
|
41
Exelixis
EXEL
$10.1B
| $37.3M | 0.39% | 1,515,000 -2,000,000 | -57% | -$49.3M |
|
|
CAB
42
DELISTED
Cabela's Inc
CAB
| $35.9M | 0.37% | +605,000 | New | +$35.9M |
|
43
FibroGen
FGEN
$47.8M
| $34.6M | 0.36% | 1,072,000 +390,000 | +57% | +$12.6M |
|
|
RC
44
Ready Capital
RC
$700M
| $34.5M | 0.36% | 2,324,236 | – | – |
|
45
Amicus Therapeutics
FOLD
$2.34B
| $30.2M | 0.31% | +3,000,000 | New | +$30.2M |
|
|
TRCO
46
DELISTED
TRIBUNE MEDIA COMPANY CLASS A
TRCO
| $30M | 0.31% | +735,000 | New | +$30M |
|
47
Ryanair
RYAAY
$33.7B
| $25.7M | 0.27% | 238,813 +55,098 | +30% | +$5.93M |
|
|
MON
48
DELISTED
Monsanto Co
MON
| $25.4M | 0.26% | +215,000 | New | +$25.4M |
|
|
GNCMA
49
DELISTED
GCI Liberty, Inc. Class A-1 Common Stock
GNCMA
| $23.4M | 0.24% | +638,976 | New | +$23.4M |
|
50
Grifois
GRFS
$6.78B
| $22.8M | 0.24% | 1,079,874 | – | – |
|